• SR 11302: Selective AP-1 Transcription Factor Inhibitor in C

  2026-06-01

  SR 11302 is a selective AP-1 transcription factor inhibitor that blocks tumorigenic signaling without activating retinoid receptors, minimizing side effects. It demonstrates potent, cell-type specific antiproliferative effects in multiple cancer models and has robust solubility and stability profiles for laboratory use.

• Penicillin G Sodium: Applied Protocols and Advanced Lab Use

  2026-06-01

  Penicillin G Sodium empowers researchers with reliable, high-purity protection against Gram-positive contamination, ensuring experimental reproducibility and robust infection modeling. This guide details step-by-step protocols, workflow integration, and troubleshooting insights for maximizing the impact of this natural penicillin antibiotic across diverse laboratory settings.

• Quercetin as a PI3K Inhibitor: Optimizing Cancer Research Wo

  2026-05-31

  Quercetin, a dietary flavonoid and potent PI3K inhibitor, enables robust experimental workflows in cancer and liver injury research by targeting intracellular signaling and ferroptosis. This article translates cutting-edge mechanistic evidence into practical protocols, troubleshooting strategies, and comparative insights for advanced assay optimization.

• Human iPSC Sensory Neurons Model HSV-1 Latency and Reactivat

  2026-05-30

  This study establishes a scalable protocol for differentiating human inducible pluripotent stem cells (hiPSCs) into sensory neurons that robustly support HSV-1 latency and reactivation. The model recapitulates key molecular hallmarks of HSV-1 latency in human neurons, providing a critical platform for mechanistic and therapeutic research targeting latent viral reservoirs.

• Biotin-HPDP in Immuno-Oncology: Precision Protein Labeling f

  2026-05-29

  Discover how Biotin-HPDP enables high-specificity protein biotinylation for advanced immuno-oncology assays, including PD-L1 detection and affinity purification. Explore mechanistic insights and protocol optimizations that set this reagent apart.

• Jasplakinolide: Precision Actin Polymerization Inducer Workf

  2026-05-29

  Jasplakinolide, as a high-affinity actin polymerization inducer, empowers advanced cytoskeletal research by enabling robust manipulation of actin dynamics in living cells and in vitro systems. This article translates cutting-edge protocols and troubleshooting strategies into actionable guidance, showcasing APExBIO’s Jasplakinolide as a transformative tool for cell biology, imaging, and antifungal studies.

• D-Luciferin Potassium Salt: Optimizing In Vivo Bioluminescen

  2026-05-28

  D-Luciferin (potassium salt) empowers real-time, non-invasive in vivo bioluminescence imaging for precise tumor cell tracking and reporter assays. Its superior water solubility and assay reproducibility give researchers robust, scalable workflows—especially when high-throughput sensitivity and workflow reliability are critical.

• Spatial Sampling Protocols Reveal Infection Dynamics in Ambr

  2026-05-28

  Masoudi et al. present a detailed protocol for investigating infectious disease dynamics and pathogen spread within social ambrosia beetle colonies, focusing on Xyleborus affinis. Their approach integrates spatial sampling, infection assays, and imaging to enable reproducible study of microbe-insect interactions, with broad implications for symbiont ecology and disease transmission research.

• IMPDH Inhibition: Merimepodib as a Translational Bridge

  2026-05-27

  This thought-leadership article explores how targeted IMPDH inhibition with Merimepodib (VX-497) unlocks new strategies for translational researchers across oncology, immunology, and virology. By synthesizing mechanistic insights and referencing breakthrough findings on viral metabolic hijacking, we offer strategic guidance for deploying Merimepodib in advanced experimental models. The piece distinguishes itself by bridging domains and giving actionable, protocol-focused recommendations.

• EZ Cap™ Firefly Luciferase mRNA: Enhanced Reporter Workflows

  2026-05-27

  EZ Cap™ Firefly Luciferase mRNA with Cap 1 structure delivers unparalleled stability and translation efficiency for bioluminescent reporter assays. Its advanced engineering supports robust mRNA delivery, in vivo imaging, and gene regulation studies, outperforming traditional reporters in sensitivity and reproducibility.

• Alternative Splicing of AGL18-1 Regulates Flowering in Brass

  2026-05-26

  This study elucidates how alternative splicing of the AGL18-1 gene in Brassica juncea generates two isoforms with distinct roles in floral timing. The findings provide mechanistic insights into photoperiod-dependent flowering regulation, with implications for crop trait optimization.

• RepSox (ALK5 Inhibitor): Evidence, Use, and Workflow Paramet

  2026-05-26

  RepSox is a potent and selective ALK5 inhibitor that disrupts TGF-β signaling and enables efficient induced pluripotent stem cell (iPSC) reprogramming. Its nanomolar-range activity and protocol adaptability make it a robust tool for cell differentiation and transformation studies. Quantitative evidence supports its use in reproducible, high-yield workflows.

• EdU Imaging Kits (Cy3): Precision S-Phase DNA Synthesis Dete

  2026-05-25

  EdU Imaging Kits (Cy3) enable precise measurement of S-phase DNA synthesis, leveraging click chemistry for superior sensitivity over legacy assays. The kit preserves cell morphology, supports multiplexing, and is optimized for both microscopy and flow cytometry. Its workflow eliminates DNA denaturation, minimizing sample degradation.

• Biotin-HPDP (N-[6-(biotinamido)hexyl]-3’-(2’-pyridyldithio)p

  2026-05-25

  This article explores practical laboratory challenges in thiol-specific protein labeling and demonstrates how Biotin-HPDP (N-[6-(biotinamido)hexyl]-3’-(2’-pyridyldithio)propionamide), SKU A8008, offers reproducible, evidence-based solutions. We present scenario-based Q&A blocks rooted in real experimental needs and bridge to validated workflows, emphasizing the reagent's versatility for cell viability, redox biology, and affinity purification.

• Dual-Action Inhibitors Accelerate p38α MAPK Dephosphorylatio

  2026-05-24

  This study uncovers how certain kinase inhibitors not only block p38α MAPK activity but also promote its dephosphorylation by phosphatases, revealing a dual-action mechanism. These structural and functional insights inform new strategies for achieving specificity and potency in inflammation research and therapeutic design.

16199 records 1/1080 page Next 12345 下5页 Last page